ReviewJournal of thrombosis and thrombolysis2017
Venous thromboembolism in chronic kidney disease: epidemiology, the role of proteinuria, CKD severity and therapeutics.
Review in Journal of thrombosis and thrombolysis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- Efficacy and safety of oral anticoagulants in the treatment of chronic kidney disease with atrial fibrillation or venous thromboembolism: a systematic review and meta-analysis.Frontiers in pharmacology · 2025Pooled it
- Review
- Cardiovascular Risk and Its Presentation in Chronic Kidney Disease.Journal of clinical medicine · 2025Review
- Association between Genetic Risk and the Renal Function for Developing Venous Thromboembolism.Journal of atherosclerosis and thrombosis · 2025Article
- Prevalence, risk, and outcome of deep vein thrombosis in acute respiratory distress syndrome.Thrombosis journal · 2021Article
- Proteinuria and venous thromboembolism in pregnancy: a population-based cohort study.Clinical kidney journal · 2021Article
- Review
- Estrogen and estrogen receptors in kidney diseases.Renal failure · 2021Review
- Health risk of travel for chronic kidney disease patients.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2020Review
- Increased risk of deep vein thrombosis in end-stage renal disease patients.BMC nephrology · 2018Article
- Potential Pathogenesis and Biomarkers of Kidney Cancer-Related Stroke.Medical science monitor : international medical journal of experimental and clinical research · 2017Article
- Venous thromboembolism prophylaxis in inflammatory bowel disease flare-ups.Annals of gastroenterologyArticle
- Factors Associated with Different Survival Functions in Anticoagulated Patients with Chronic Kidney Disease.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The worldwide prevalence of chronic kidney disease is 10-15 % of the adult population, is rising and increases susceptibility to venous thromboembolism (VTE). In this narrative review we discuss the underlying evidence behind the association of VTE/CKD and examine the role of worsening CKD stage, proteinuria, and the risk of recurrent VTE. As CKD may alter therapeutic options we discuss the role of emerging therapies, the non-vitamin K oral anticoagulants (NOAC), in the treatment of VTE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.